The first generic weight-loss GLP-1 injection Sevmia was recently approved by Health Canada. Here’s what you need to know.

Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and ...

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist and the active ingredient in the medications Wegovy and Ozempic. Both Wegovy and Ozempic are available in injectable forms you ...

The Wegovy weight loss pill is now available to buy in the UK, offering patients access to GLP-1 semaglutide medication ...

By Nqobile Dludla JOHANNESBURG, July 17 (Reuters) - Novo Nordisk will launch a more affordable authorised copy of its Ozempic diabetes drug in South Africa later this month, partnering with healthcare ...

As use of GLP-1s surged across the U.S., average total payments per user also climbed sharply, according to a new ...

The hidden cost GLP boom shows total payments rose sharply from 2017-2022 despite lower out-of-pocket costs, impacting insurers and Medicare programs.

The arrival of generic semaglutide in Canada marks a major turning point for one of the world’s most closely watched ...

A new Medicare GLP-1 Bridge program offers Wegovy and Zepbound to eligible seniors for $50 a month starting July 1, slashing obesity drug costs.

UK patients can now buy the daily pill version of semaglutide (Wegovy) for weight loss. The pill is available privately for ...

By Nqobile Dludla JOHANNESBURG, July 15 (Reuters) - India's Sun Pharmaceutical Industries has received approval from South Africa's health regulator to manufacture and sell a generic version of ...

India’s GLP-1 gold rush is fading as generic semaglutide sales slow, inventories pile up and patients quit over side effects, costs and unrealistic weight-loss expectations. Discover why the market is ...